chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was stored in refrigerator on 04-Jun-2022 and was administered on 20-Jul-2022; No adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and was administered on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 20-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and was administered on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and was administered on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and was administered on 20-Jul-2022).    No concomitant medications were reported. The vial was initially stored in the refrigerator on 04-Jun-2022. Patient received half dose. The vial did not undergo any temperature excursions. No treatment medications were reported
Moderna Dose 1 2/5/21 (016M20A) Moderna Dose 2 3/5/21 (013A21A) COVID Positive 9/18/21  9/20/21: -Patient is an 89yo male with medical history of tobacco use  -History obtained from ER provider and chart review. Daughter unreachable on phone and patient very fatigued  -Presenting because of worsening COVID symptoms, anorexia , dehydration  -Tested COVID positive on 9/18  -In the ER he was febrile 100.5F, HR 96bpm, BP 111/67 with oxygen saturation of 91-96% on room air  -CXR showed interval increased bilateral pulmonary infiltrate.  -Labs remarkable for glucose 140, Cr 2.57,ast 57, normal lactate, trop 0.04 , Hb 11.5  -He recieved 1L NS bolus  -Patient will be admitted under hospitalist service for dehydration and AKI due to COVID  10/4/21: Patient is on 100 % FIO2 on BIpAP. I discussed with his sons who have agreed about the poor prognosis and change him to DNR status with comfort measures, but they would like to continue supportive measures for the moment. Per family request pt taken off BiPAP for comfort cares, Dr. aware. Patient passed away.
Mom treated child for fever at 12:30 AM at home. Brought child to ER stating child had had seizure for 10 seconds. Temp 104.1 oral and was given Tylenol supp - was also treated for URI with Amoxicillin 250mg po stat, Motrin 160mg po stat. Was given prescriptions Augmentin 600mg bid. 5/15/03 phoned client - father reports improvement.
3 pts in the reporting MD office did not respond p/receiving a series of 3 vax of Engerix-B;
On 12/9/21 at approximately 07:10AM the patient was found to be in respiratory distress, rhonchi in the lungs, dried emesis on the face, rambling speech, vital signs were tachycardia 156 HR, O2 saturation was 78 on room air, temperature was 103 degrees Fahrenheit, respirations were 24 and BP was 156/62.
pt recvd vax;13jan v once; on 16jan had fever of 102.5 w/ apap & cont to vomit;on 17jan95 fever down & stopped vomiting;18jan no oth sxs;did not contact MD during episode;
10am pt received Hep A 2. By 3pm he described swelling of bottom lip. No other signs or symptoms reported. By 6/21/07 10am pt says swelling going down and "appeared to be getting better".
This spontaneous report as received from a pharmacist refers to two patients of unknown age and gender. Concurrent conditions and medical history were not reported. The pharmacist reported that on 23-SEP-2015, the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # L006382, expiration date 25-MAY-2016) (Dose and route were not provided). Concomitant medication was not reported. No adverse effects reported. This is one of several reports from same source. Additional information is not expected because the pharmacist decline to provide patient's or physician's information at this time.
Vaccine 1 - 7 days after shot mild diarrhea thought to be colitis flare-up.   Vaccine 2 - 7 days after shot moderate diarrhea, acute kidney failure from dehydration.  COVID positive.  Diagnosed COVID colitis. Vaccine 3 - 7 days after shot severe vomiting and diarrhea, acute kidney failure from dehydration. COVID negative.  Influenza negative.
Arrived to ER on 9/13/2021. Patient is an 81-year-old female with advanced dementia, diabetes,  hypertension, tested positive for COVID on 09/08/2021.  Was vaccinated  approximately 7 months ago with Pfizer.  Has not been eating.  Has episodes of  desaturation below 90% on room air.  Patient unable to provide any history  whatsoever. Admitted to hospital on 9/13/21. She started on decadron, keep oxygen above 90%. I covered her with abx due to possible superimposed bacterial GNR PNA. She was tested positive for COVID on 09/08/2021. She was vaccinated approximately 7 months ago with Pfizer. Was started her on remdesivir 9/14; started on doxycycline and ceftriaxone. CTA confirmed Covid-19 PNA and possible superimposed RLL PNA GNR; no signs of PNA. Pt developed acute hypoxic respiratory failure with increasing oxygen requirement on 9/15. She is now on HFNC 60 liters. Niece is aware of deterioration. Ct with supportive measures.  Due to worsening of respiratory status. Talked with POA the niece and patient placed on comfort on 9/18. She was on IV prn morphine and IV ativan prn.  She passed away on 9/19/21 01:02AM
Patient was inadvertently given a booster dose of Pfizer (purple cap) too soon.  Per CDC, booster dose should be given at least 5 months after dose 2.  Patient received dose 2 on 10/9/21 and the booster was given 2/26/22.  According to the CDCs guidance on administration errors and deviations, the patient does NOT need to repeat the booster dose.
Sudden onset palpitations. Noted to have Afib with RVR of 150-160.
Fever and chills started about 22 hours after and lasted one day. Shot site has been sore and is still sore.  Round red circle about two inches below injection site showed up 2 days after the shot. About 2.5 inch diameter. It hurts and occasionally itches.  No medical treatment sought so far. I have taken ibuprofen and Tylenol.
Information has been received from a 23 year old female consumer with anxiety who on approximately 17-JUL-2007 was vaccinated with the first dose of GARDASIL.  On 24-JAN-2008 she had received her third dose of GARDASIL and that same day she also has a PAP test done.  Then on 05-FEB-2008 she found out that her PAP test came back abnormal for one of the high risk forms of HPV.  Unknown medical attention was sought.  Patient outcome is unknown.  No product quality complaint was involved.  Additional information has been requested. 07/08/08 The office does not know of the above patient. No further information is available.
Injection site reaction. A physician reported that an infant received her 2nd dose of Prevnar along with her 1st dose of Varicella on 4/16/01. Nine days later the child developed an injection site reaction at the Prevnar site, characterized by redness, warmth and hardness.
Administered vaccine had been in the refrigerator > 30days and was expired; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine had been in the refrigerator > 30days and was expired) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine had been in the refrigerator > 30days and was expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine had been in the refrigerator > 30days and was expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 12-SEP-2014 the patient was vaccinated with an expired dose of (RECOMBIVAX HB) (lot # J001183, expiration date: 08-SEP-2014, dosage unknown, intramuscular. No known adverse effects. Additional information has been requested.
Severe head and body aches, no fever, allergic welts on left temple. Got relief a couple hours after taking hydrocodone for severe pain in the night and was able to return to sleep. Upon waking, the flu-like symptoms appeared. Sodium naproxen provided some relief. It has been 30 hours since the vaccine and am still very ill.
Child was seen at County Health Center on 110310 for initial immunizations. Child was alert without any problems noted or voiced.
worst flu like symptoms, felt terrible; felt terrible; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (worst flu like symptoms, felt terrible) and FEELING ABNORMAL (felt terrible) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 215M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was provided.).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (worst flu like symptoms, felt terrible) and FEELING ABNORMAL (felt terrible). On 15-Feb-2021, INFLUENZA LIKE ILLNESS (worst flu like symptoms, felt terrible) and FEELING ABNORMAL (felt terrible) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
A week after my injection I got itchiness and a small rash on my arm at the injection site.
12 hours post vaccine - muscle pain, difficulty moving, headache.  A few hours later - chills, sweats, fever of 101.0, continued muscle pain and headache, throbbing pains
The day after the vaccine, I got a tingling feeling seemingly along my sciatic nerve in my left leg, later in the day. It remained a tingly feeling for about a week after that, and then turned into a shooting pain feeling. 3 weeks later (still, today) I am having pain in my left leg.
Red, swollen, warm, and painful left arm from his kinrix 2 days ago.  Approximately 3 inches around.  No fever present.
I noticed right away after the vaccine, I noticed nerve pain through my body. I noticed a headache. I had some weird stomach pain (kind of sharp, nerve pain) that was on my right side. It felt sudden and it startled me. It ended up going away - that happened four or five times the first day. The next day, I woke up with migraine headache - told doctor experienced nausea, vomiting, sweating.  That migraine lasted three or four days. I was taking Imitrex (I take it as needed - 2 a day) and that was not helping. It was a horrible headache. I saw the PCP and the rheumatologist and they did a nerve block which helped. The nerve block was about a month ago. And that worked for about a month but now I'm having migraines again. I am still having a lot of the nerve pain. The doctor said that I have pre-anti-fossid lipid - syndrome (APS) - and was concerned about clots.
Patient is a 63 yo female.  She was vaccinated on 3/19/03.  Early in the morning on 3/24/03 she woke up in a drenching sweat, feeling weak, with muscle aches.  She was not able to fall back asleep.  Morning 3/25 she noticed a pustule on her cheek, 2mm below the right corner of her mouth.  Pustule was filled with while pus, she put a hot compress on it, and it broke.  Later that day she noticed another pustule on the right hand between the 2nd and 3rd digits, later she noticed a 3rd pustule on the medial side of her left elbow.  Initially, the lesions were painful, then improved, then more painful again by 3/28.  On 3/28 the mouth and elbow lesions were pink, with a clean, erythematous base.  The right hand lesion was dry, dark, but without a real eschar.
APPROXIMATELY 30 MINUTES AFTER VACCINATION, DEVELOPED DIZZINESS AND PRESSURE IN CHEST THAT LASTED UNTIL THE FOLLOWING MORNING.
Cellulitis of skin on arm at site of injection (seen 10/22 for pain) and treated with KEFLEX 500mg BID x 1 wk.
Fever of 101.8, moderate muscle ache over entire body, headache, chills, red eyes (with some white-ish discharge), racing heart beat, swelling of face, fingers, injection site soreness, sore throat. Symptoms were extreme enough to force bed rest. Took Ibuprofen which eased the symptoms.  Most symptoms were gone by following morning except injection site soreness.
Headache; muscle soreness; general all over the body soreness; her arm was very sore/ This was at the injection site; a low grade fever/ a fever of 101.0; chills; This is a spontaneous report from a contactable registered nurse (patient). A 52-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142, Expiry Date: Mar2021), via an unspecified route of administration in the left biceps of her arm on 05Jan2021 07:15 at single dose for COVID-19 immunization. Medical history included positive on 19Dec2020 for the COVID virus. She had no allergies. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported a side effect she experienced after having the shot. Afterward her arm was very sore. The patient got it at 7:15 am and it didn't feel the sore until about midway through the day (05Jan2021). This was at the injection site. When she got home she had chills and a low grade fever (05Jan2021) so she took Tylenol. The morning (06Jan2021) she woke up with headache and a fever of 101.0. She still had the muscle soreness, it was more at the administration site but there was some general all over the body soreness too. The patient explained she was positive on 19Dec2020 for the COVID virus and felt like these were the same symptoms she had with the virus. When asked about a seriousness criteria, she stated she reported that her fever improved with the Tylenol and she was feeling better now. The outcome of soreness at injection site was not recovered, of fever, headache was recovering, of the other events was unknown. No emergency room or physician office was involved. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.
Tinnitus; Coughing; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 16:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 21Apr2021 at 12:00 the patient experienced tinnitus and coughing. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events tinnitus and coughing were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, diarrhea, chills, body aches, low grade fever. Started 24 hours after vaccine. Currently taking acetaminophen for fever and aches.
1st shot: bad headaches, muscle ache, dizzy, nauseated 2nd: numb fingers, bad headaches, muscle ache, naseated
Chest pain; Feeling flushed; Sweating; Anxious/She has anxiety so any little thing freaks her out; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 22-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 11Aug2021 (age at vaccination was unknown) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of Pfizer COVID 19 vaccine yesterday 11Aug2021. On an unspecified date in Aug2021, the patient experienced chest pain, felt flushed and sweating. She had baseline anxiety and she shared she was anxious now as she was experiencing the side effects. She asked if that was normal. It felt like someone was sitting on her chest. She had anxiety so any little thing freaked her out. The patient asked if those were reported side effects from vaccine. She received the response stating that chest pain noted sweating, feeling flushed and anxiety are not listed as side effects. These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. The patient was referred to HCP for diagnosis and treatment. The case was assessed as non-serious. The outcome of the events was unknown  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
chills                                                                  onset:   10 hours after injection,  lasting  9 hours tachycardia            hr to 120s                onset:   11 hours after injection, persisting overnight  (approx  8 hours) soreness at/around injection              onset:   day 1 after injection, persisting  2 days
at day 10 light red round circle surrounding injection site. each day heat and swelling gets bigger and bigger
Pt received 2 mo immunizations on March 15, 2011, then developed maculopapular rash - trunk/arms/legs approx. 24 hours later.
Patient presented in the office with her left arm pink, warm to the touch, and itchy. This reaction was at the injection site. Arm was also inflamed. Dr. believed this was an adverse drug reaction and instructed to observe for now.
Pt. called center to have symptom evaluated after receing tetanus vaccine . Pt. said she had experienced dizziness, pain numbness and tingling in left arm after leaving center, symptoms started about noon. Upon evaluation instructed to seek outside care for further evaluation , unable to determine if related to plasma donation or the vaccine. Pt. stated the dizziness had resolved continued to have numbness and tingling in l-arm
Low fever; Headache; Body ache; Hsv outbreak; Bad mouth tasting; This is a spontaneous report from a non-contactable healthcare professional. A 33-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021(at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, hypertension and hsv. Concomitant medications included metformin (MANUFACTURER UNKNOWN), vildagliptin (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 17:15, the patient had low fever (38.3: Unspecified units), Hsv outbreak, headache, body aches and bad mouth tasting. Therapeutic measure taken for the adverse events included treatment with ZOVIRAX on an unspecified date. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of low fever (38.3), Hsv outbreak, headache, body aches and bad mouth tasting were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Day after vaccination large area of redness and induration noted approximately 8cm diameter around vaccination site on lateral right thigh. It increased over the following 24 hours to approximately 9.5cm diameter on re-presentation to our office on 9/25/17. The area is discretely bounded, firm, light red, non tender, minimally itchy.  No fever or change in activity or other symptoms present.
Fatigue; Dry mouth; Low grade fever; Chills; Headache; Itchy rash at injection site; Itchy rash at injection site; Soreness at injection site; This is a spontaneous report from a non-contactable nurse (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1685), via an unspecified route of administration on 31Dec2020 12:45 at left arm, at single dose for covid-19 immunization. Medical history known allergies: penicillin, chocolate from an unknown date. Concomitant medication included acetylsalicylic acid (ASPIRIN) and Birth control pills. The patient previously took erythromycin and known allergies: Erythromycin. The patient was not pregnant at the time of vaccination. The patient experienced fatigue, dry mouth, low grade fever, chills, headache, itchy rash at injection site, soreness at injection site on 31Dec2020 15:00. No treatment was received for all events. The outcome of the events was recovered on an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No seriousness criteria: no Results in death, no Life threatening, no Caused/prolonged hospitalization, no Disabling/Incapacitating, no Congenital anomaly/birth defect.  No follow up attempts are possible. No further information is expected.
This spontaneous report as received from a consumer refers to an unspecified number of patients of unknown age and gender. ON an unknown date, the patient were vaccinated with ZOSTAVAX (dose, route and lot # not reported). Since unknown date patients dragged shingles on for years, with extreme nerve damage. The outcome of the events was not reported. The relationship between ZOSTAVAX and the events was not reported. This case is linked to cases 1309USA010583, 1308USA003078 via same reporter link. Additional information has been requested.
Medical Center was contacted by Med Center on 06/20/2019 reporting patient had presented to their facility with redness, swelling and rash to injection site.